A 60 year old man with longstanding hypertension and dyslipidaemia has an office blood pressure of 152/92 mmHg despite adherence to lifestyle changes and monotherapy with an ACE inhibitor at maximum tolerated dose. His 5 year absolute CVD risk is 18%. Which of the following is the most appropriate next pharmacological step?